Sarah L Gemberling

Sarah L. Gemberling, PhD, RAC, is a highly experienced regulatory affairs professional with a strong background in clinical trials and oncology. Currently serving as Senior Manager of Regulatory Affairs at United Therapeutics Corporation since May 2018, Sarah has held various positions in regulatory affairs within the organization. Previous roles include Regulatory Affairs Scientist at Duke University and Regulatory Coordinator II at Duke Cancer Institute, where responsibilities included regulatory operations for clinical trials in GU oncology. Sarah's academic journey includes a PhD in Molecular Cancer Biology from Duke University, supported by a BS in Molecular Biology from the University of Michigan, where initial research focused on signaling pathways in yeast and synaptic proteins.